HİDRADENİTİS SUPPURATİVANCT07294456
Periodontal Status and Disease Severity in Hidradenitis Suppurativa Patients
An observational study of HİDRADENİTİS SUPPURATİVA, run by Saglik Bilimleri Universitesi at 1 site in Turkey (Türkiye).
Trial summary
This cross-sectional study aims to evaluate the periodontal status of individuals diagnosed with hidradenitis suppurativa (HS) and to compare them with systemically healthy controls. Read more about this study
- Who is it for?
- Ages 18 minutes and olderHealthy volunteers can take part
- Conditions the study is for
- HİDRADENİTİS SUPPURATİVA
- How many people
- 226 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Jun 2025to 15 Sep 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 minutes and older
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: The study population consists of adult individuals with a confirmed diagnosis of hidradenitis suppurativa and age-matched healthy controls, each having at least 12 teeth (excluding third molars), and no recent periodontal or systemic treatment.
Who may be able to join
- Having a diagnosis of hidradenitis suppurativa.
- Age greater than 18 years.
- Presence of at least 12 teeth in the mouth, excluding third molars.
Who cannot join
- Age under 18 years.
- Pregnancy.
- Breastfeeding.
- Receiving treatment for periodontitis or hidradenitis suppurativa within the past 3 months.
- Use of antibiotics, anti-inflammatory drugs, or immunomodulatory medications within the past 3 months.
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
University of Health Sciences, Gülhane Faculty of Dentistry
Ankara, None Selected, 6220
About this study
Official title: Evaluation of Periodontal Status in Individuals With Hidradenitis Suppurativa: A Cross-Sectional Study
This cross-sectional study aims to evaluate the periodontal status of individuals diagnosed with hidradenitis suppurativa (HS) and to compare them with systemically healthy controls. HS is a chronic inflammatory skin disease characterized by recurrent lesions and systemic inflammation, which may influence periodontal health. In this study, periodontal parameters-including probing depth, clinical attachment loss, gingival index, plaque index, and bleeding on probing-will be assessed using standard clinical methods. Dermatological examination will include disease duration, lesion characteristics, and Hurley staging. The study will investigate the prevalence of periodontitis in HS patients and explore potential associations between periodontal findings and HS severity. Findings from this research may provide insight into shared inflammatory pathways and contribute to understanding the possible link between HS and periodontal disease.
- Conditions
- HİDRADENİTİS SUPPURATİVA
- Being tested
- No intervention (observational study)
- Keywords
- HİDRADENİTİS SUPPURATİVA, PERİODONTAL DİSEASE, PERİODONTİTİS, GİNGİVAL İNFLAMMATİON
- Medical subject headings
- Hidradenitis Suppurativa, Gingival Diseases, Dry Socket, Gingivitis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
No intervention (observational study)Other
Observational study with no treatment or intervention applied.
| Study group | Role | What they receive |
|---|---|---|
| Hidradenitis Suppurativa Group | Participants diagnosed with hidradenitis suppurativa undergoing periodontal examination. Receives: Other: No intervention (observational study) | |
| Healthy Control Group | Systemically healthy individuals without hidradenitis suppurativa undergoing periodontal examination. Receives: Other: No intervention (observational study) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Correlation Between Periodontal Status and Hidradenitis suppurativa
Measured: Baseline (single assessment)
Secondary outcomes (3)
Correlation between Periodontal Status and Hurley Stage
Measured: Baeline (single assesment)
Corralation between Hurley Stage and Oral Health Impact Profile OHIP-14) Score
Measured: baseline (single assesment)
Correlation between Dermatology Life Quality Index (DLQI) and Oral Health Impact Profile (OHIP-14) Total Score
Measured: baseline (single assesment)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Dec 2025
- Study start1 Jun 2025
- Primary completion1 Sep 2025
- Study completion15 Sep 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for HİDRADENİTİS SUPPURATİVAStudies of the same condition, open and under way.
- More trials run by Saglik Bilimleri UniversitesiThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Prospective
- Enrolment
- 226 participants (actual)
Sponsor and investigators
- Lead sponsor
- Saglik Bilimleri Universitesi
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Şeyma Çardakçı, Saglik Bilimleri Universitesi
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07294456
- Sponsor's protocol ID
- SUDE1824
- Status last verified
- Dec 2025
- First submitted
- 8 Dec 2025
- Last updated
- 29 Dec 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 29 Dec 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of Periodontal Status in Individuals With Hidradenitis Suppurativa: A Cross-Sectional Study
- ClinicalTrials.gov ID
- NCT07294456
- Acronym / sponsor ID
- SUDE1824
- Conditions
- HİDRADENİTİS SUPPURATİVA
- Keywords
- HİDRADENİTİS SUPPURATİVA, PERİODONTAL DİSEASE, PERİODONTİTİS, GİNGİVAL İNFLAMMATİON
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 226 participants (actual)
- Lead sponsor
- Saglik Bilimleri UniversitesiUniversity, hospital or other
- Study start
- 1 Jun 2025 (actual)
- Primary completion
- 1 Sep 2025 (actual)
- Study completion
- 15 Sep 2025 (actual)
- First posted
- 19 Dec 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This cross-sectional study aims to evaluate the periodontal status of individuals diagnosed with hidradenitis suppurativa (HS) and to compare them with systemically healthy controls. HS is a chronic inflammatory skin disease characterized by recurrent lesions and systemic inflammation, which may influence periodontal health. In this study, periodontal parameters-including probing depth, clinical attachment loss, gingival index, plaque index, and bleeding on probing-will be assessed using standard clinical methods. Dermatological examination will include disease duration, lesion characteristics, and Hurley staging. The study will investigate the prevalence of periodontitis in HS patients and explore potential associations between periodontal findings and HS severity. Findings from this research may provide insight into shared inflammatory pathways and contribute to understanding the possible link between HS and periodontal disease.
Study design
- Observational model
- Case-control
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Hidradenitis Suppurativa Group | – | Other: No intervention (observational study)Participants diagnosed with hidradenitis suppurativa undergoing periodontal examination. |
| Healthy Control Group | – | Other: No intervention (observational study)Systemically healthy individuals without hidradenitis suppurativa undergoing periodontal examination. |
Who may qualify
- Ages
- 18 minutes and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- The study population consists of adult individuals with a confirmed diagnosis of hidradenitis suppurativa and age-matched healthy controls, each having at least 12 teeth (excluding third molars), and no recent periodontal or systemic treatment.
Key inclusion criteria (3 listed)
- Having a diagnosis of hidradenitis suppurativa.
- Age greater than 18 years.
- Presence of at least 12 teeth in the mouth, excluding third molars.
Key exclusion criteria (5 listed)
- Age under 18 years.
- Pregnancy.
- Breastfeeding.
- Receiving treatment for periodontitis or hidradenitis suppurativa within the past 3 months.
- Use of antibiotics, anti-inflammatory drugs, or immunomodulatory medications within the past 3 months.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| No intervention (observational study)Observational study with no treatment or intervention applied. | Other | Healthy Control Group, Hidradenitis Suppurativa Group |
Primary outcome
Correlation Between Periodontal Status and Hidradenitis suppurativa
Time frame: Baseline (single assessment)
3 secondary outcomes
Correlation between Periodontal Status and Hurley Stage
Time frame: Baeline (single assesment)
Corralation between Hurley Stage and Oral Health Impact Profile OHIP-14) Score
Time frame: baseline (single assesment)
Correlation between Dermatology Life Quality Index (DLQI) and Oral Health Impact Profile (OHIP-14) Total Score
Time frame: baseline (single assesment)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Dec 2025.
- Individual participant dataSharing planned: Undecided
Related trials for HİDRADENİTİS SUPPURATİVA
Not yet recruiting
Early Pathophysiology of Hidradenitis Suppurativa and Prediction of the Risk of Progression: a Prospective Cohort
Hidradenitis Suppurativa (HS)
Active, not recruitingPhase 2
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Active, not recruiting
Acceptability of MBSR for People With HS
Hidradenitis Suppurativa (HS)
RecruitingPhase 3
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
Hidradenitis Suppurativa (HS)
RecruitingPhase 2
ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa
Hidradenitis Suppurativa (HS)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of HİDRADENİTİS SUPPURATİVA, run by Saglik Bilimleri Universitesi at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 29 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Correlation Between Periodontal Status and Hidradenitis suppurativa (time frame: Baseline (single assessment)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Dec 2025.